z-logo
open-access-imgOpen Access
Structure of anabolic ornithine carbamoyltransferase from Campylobacter jejuni at 2.7 Å resolution
Author(s) -
Shabalin I. G.,
Porebski P. J.,
Cooper D. R.,
Grabowski M.,
Onopriyenko O.,
Grimshaw S.,
Savchenko A.,
Chruszcz M.,
Minor W.
Publication year - 2012
Publication title -
acta crystallographica section f
Language(s) - English
Resource type - Journals
ISSN - 1744-3091
DOI - 10.1107/s1744309112031259
Subject(s) - trimer , crystallography , stereochemistry , chemistry , ornithine , campylobacter jejuni , protein subunit , protein structure , aspartate carbamoyltransferase , ornithine carbamoyltransferase , arginine , biochemistry , enzyme , biology , amino acid , allosteric regulation , dimer , organic chemistry , bacteria , gene , genetics
Anabolic ornithine transcarbamoylase (aOTC) catalyzes the reaction between carbamoyl phosphate (CP) and l ‐ornithine (ORN) to form l ‐citrulline and phosphate in the urea cycle and l ‐arginine biosynthesis. The crystal structure of unliganded aOTC from Campylobacter jejuni (Cje aOTC) was determined at 2.7 Å resolution and refined to an R work of 20.3% and an R free of 24.0%. Cje aOTC is a trimer that forms a head‐to‐head pseudohexamer in the asymmetric unit. Each monomer is composed of an N‐terminal CP‐binding domain and a C‐terminal ORN‐binding domain joined by two interdomain helices. The Cje aOTC structure presents an open conformation of the enzyme with a relatively flexible orientation of the ORN‐binding domain respective to the CP‐binding domain. The conformation of the B2–H3 loop (residues 68–78), which is involved in binding CP in an adjacent subunit of the trimer, differs from that seen in homologous proteins with CP bound. The loop containing the ORN‐binding motif (D xxx SMG, residues 223–230) has a conformation that is different from those observed in unliganded OTC structures from other species, but is similar to those in structures with bound ORN analogs. The major differences in tertiary structure between Cje aOTC and human aOTC are described.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here